Solriamfetol and CBT-I in Patients With Insomnia Disorder

Summary

Medication is FDA approved. The objective of this project is to test the efficacy of solriamfetol for treating insomnia (alone and in combination with Cognitive Behavioral Therapy for Insomnia \[CBT-I\]). Ultimately, this study will test whether wake extension (regardless of how it is achieved) will consolidate sleep and improve sleep continuity.

Timeline

Start

2023-07-31

Primary completion

2026-01-31

Completion

2026-04-30

Drugs

Indications